| 证券代码：688772 | 证券简称：珠海冠宇 | 公告编号：2025-054 | | --- | --- | --- | | 转债代码：118024 | 转债简称：冠宇转债 | | 珠海冠宇电池股份有限公司 关于 2024 年年度权益分派实施后调整回购股份价格 上限的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 调整前回购股份价格上限：不超过人民币 23.00 元/股（含） 根据公司《关于第二期以集中竞价交易方式回购公司股份方案的公告》（以 下简称《回购方案》），若公司在回购股份期内发生派发红利、送红股、公积金转 增股本等除权除息事项的，自股价除权除息之日起，按照中国证监会及上海证券 交易所的相关规定相应调整回购价格上限。 三、本次回购股份价格上限的调整 根据《回购方案》，本次回购股份价格上限由不超过人民币 23.00 元/股（含） 调整为不超过人民币 22.70 元/股（含）。具体的价格调整计算如下： 调整后的回购价格上限=（调整前的回购价格上限-每股现金红利）/（1+流 通股份变动比例）。 ...

关于实施 2024 年年度权益分派调整可转债转股价格的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 因实施权益分派,本公司的相关证券停复牌情况如下：权益分派公告前一交易日 （2025 年 6 月 12 日）至权益分派股权登记日（2025 年 6 月 18 日）期间，本公司 可转债将停止转股，2025 年 6 月 19 日起恢复转股。 | 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌期间 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | | 118024 | 冠宇转债 | 可转债转股复牌 | | | 2025/6/18 | 2025/6/19 | | | 证券简称：珠海冠宇 | 公告编号：2025-053 | | --- | --- | --- | | 证券代码：688772 转债代码：118024 | 转债简称：冠宇转债 | | 珠海冠宇电池股份有限公司 根据《募集说明书》相关条款的规定，具 ...

上海市通力律师事务所 关于珠海冠宇电池股份有限公司 差异化分红事项之专项法律意见书 致:珠海冠宇电池股份有限公司 上海市通力律师事务所(以下简称"本所")接受珠海冠宇电池股份有限公司(以下简称 "珠海冠宇"或"公司")的委托,指派本所蔡若思律师、李琼律师(以下合称"本所律师") 根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民共和国证券法》(以 下简称"《证券法》")、《上海证券交易所上市公司自律监管指引第 7 号 -- 回购股份》(以 下简称"《自律监管指引》")、《上海证券交易所上市公司自律监管指南第2号 -- 业务 办理》等法律、法规及规范性文件(以下简称"法律、法规及规范性文件",该等法律、法 规及规范性文件不包括中国香港特别行政区、澳门特别行政区和台湾地区的法律法规)以及 《珠海冠宇电池股份有限公司章程》(以下简称"《公司章程》")的规定,就珠海冠宇 2024 年度利润分配所涉及的差异化分红(以下简称"本次差异化分红")相关事项出具法律意见。 为出具本法律意见书,本所律师已经严格履行法定职责,遵循了勤勉尽责和诚实信用 原则,对珠海冠宇本次差异化分红所涉及的相关材料及有关事项进行了必 ...

Group 1 - The company announced a temporary suspension of the conversion of its convertible bonds ("冠宇转债") due to the implementation of the 2024 annual equity distribution plan [1] - The board approved a cash dividend of RMB 0.30 per share (tax included) for all shareholders, with no capital reserve transfer to increase share capital or issuance of bonus shares [1] - The equity distribution plan was approved at the company's annual general meeting on April 28, 2025, and details were disclosed on March 31, 2025 [1] Group 2 - The suspension of the bond conversion will occur from June 12, 2025, until the equity distribution registration date, with the resumption of conversion on the first trading day after the registration date [1] - The company will announce the details of the equity distribution implementation and the adjustment of the bond conversion price on June 13, 2025 [1] - Investors interested in the details of the convertible bonds can refer to the company's prospectus disclosed on October 20, 2022 [1]

| 证券代码：688772 | 证券简称：珠海冠宇 公告编号：2025-051 | | --- | --- | | 转债代码：118024 | 转债简称：冠宇转债 | | 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌期间 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | | 118024 | 冠宇转债 | 可转债转股停牌 | 2025/6/12 | | | | 珠海冠宇电池股份有限公司 关于实施 2024 年年度权益分派时 "冠宇转债"停止转股的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 因实施权益分派，本公司的相关证券停复牌情况如下：权益分派公告前一交 易日（2025 年 6 月 12 日）至权益分派股权登记日期间，本公司可转债将停止转股。 因实施权益分派，"冠宇转债"将相应调整转股价格，具体以公司后续披 露的可转债转股价格调整公告为准。 一、2024 年年度权益分派方案的基本情况 ...

Core Viewpoint - Zhuhai Guanyu Battery Co., Ltd. has announced the progress of its second phase of share repurchase plan, which aims to buy back shares through centralized bidding, with a total expected repurchase amount between RMB 100 million and 200 million [1] Summary by Sections Share Repurchase Plan - The repurchase plan was first disclosed on April 15, 2025, and the implementation period is set for 12 months after board approval [1] - The repurchase will utilize self-owned funds and special loans for share buybacks, with a maximum repurchase price of RMB 23 per share [1] - The shares repurchased will be used for converting company convertible bonds or for employee stock ownership plans and equity incentives [1] Progress of Share Repurchase - As of May 31, 2025, the company has repurchased a total of 3,634,391 shares, accounting for 0.32% of the total share capital [1] - The total amount spent on the repurchase is RMB 44,885,154.07, with the highest transaction price at RMB 12.89 per share and the lowest at RMB 11.92 per share [1] - The repurchase activities comply with relevant laws and regulations [1] Other Matters - The company will adhere to the regulations regarding share repurchase and will make decisions based on market conditions during the repurchase period [1]

| 证券代码：688772 | 证券简称：珠海冠宇 | 公告编号：2025-050 | | --- | --- | --- | | 转债代码：118024 | 转债简称：冠宇转债 | | 珠海冠宇电池股份有限公司 关于第二期以集中竞价交易方式回购公司股份的进展 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2025/4/15 | | --- | --- | | 回购方案实施期限 | 待董事会审议通过后 个月 12 | | 预计回购金额 | 10,000万元~20,000万元 | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | √用于转换公司可转债 | | | □为维护公司价值及股东权益 | | 累计已回购股数 | 363.4391万股 | | 累计已回购股数占总股本比例 | 0.32% | | 累计已回购金额 | 4,488.5154万元 | | 实际回购价格区间 | 11.92元/股~12.89元/股 | 一、回购股份的基本情况 2025 年 4 ...

Core Viewpoint - Zhuhai Guanyu (688772) announced changes to its investment project, maintaining a total investment of RMB 4 billion despite adjustments in project content due to market conditions [6][7]. Group 1: Project Overview - The company approved the investment in a high-performance lithium-ion battery project on February 27, 2022, with a total investment of RMB 4 billion [6]. - The project will be established in the Wansheng Economic and Technological Development Zone in Chongqing [6]. - The construction content has been adjusted to focus on producing consumer battery products, with the total investment scale remaining unchanged [6]. Group 2: Financial Performance - In Q1 2025, Zhuhai Guanyu reported revenue of RMB 2.498 billion and a net profit attributable to shareholders of -RMB 23.7 million [8]. Group 3: Project Timeline - The project is expected to commence production by 2028, with the construction cycle and funding to be implemented in phases based on actual conditions [7].

Core Viewpoint - Zhuhai Guanyu has made significant announcements regarding its recent business developments, particularly in the automotive low-voltage lithium battery sector and adjustments to its investment projects, indicating a strategic focus on expanding production capabilities and diversifying product offerings [1][2][5]. Group 1: Automotive Low-Voltage Lithium Battery Business - Zhuhai Guanyu has received a notification from SAIC Volkswagen to develop and supply automotive low-voltage lithium batteries, with specific terms to be finalized in a supply agreement [1]. - The automotive low-voltage lithium battery business is a core competitive advantage for Zhuhai Guanyu, having passed audits from multiple major automotive manufacturers, including SAIC, GM, and Mercedes-Benz [1]. Group 2: Investment Project Adjustments - The company announced changes to its high-performance lithium-ion battery project in Chongqing, originally planned with a total investment of RMB 4 billion to produce 15 GWh of batteries annually, now shifting focus to consumer battery products while maintaining the same investment amount [2]. - The project is set to begin construction based on actual conditions, with a target completion date within 2028 [2]. Group 3: Production Capacity Expansion - A new lithium battery production project in Zhuhai Doumen has reached its construction peak and is expected to be completed by November this year, featuring multiple fully automated production lines and an AI big data system for smart manufacturing [4]. - The project aims to implement energy-saving technologies and strive for a "zero-carbon factory" initiative [4]. Group 4: Financial Performance and Growth Areas - In 2023, Zhuhai Guanyu reported total revenue of RMB 11.541 billion, a year-on-year increase of 0.83%, with a net profit of RMB 430 million, up 25.03% [5]. - The rapid growth in power and energy storage business segments, particularly in automotive low-voltage lithium batteries and drone batteries, accounted for 80.38% of total revenue, highlighting these areas as key growth drivers [5]. Group 5: New Business Ventures - The company is actively collaborating with various clients to accelerate the development of its robotics battery business, which is anticipated to become a new growth engine for the company [6].

Group 1 - Huapei Power received a project intention letter from a domestic new energy vehicle company for a thermal management system PTC water heater, with an estimated sales amount of approximately 9 million yuan over a 5-year lifecycle starting from 2026 [1] - Antu Biotech obtained medical device registration certificates for products including "Cytomegalovirus IgM Antibody Test Kit" [1][2] - Yihong Technology adjusted the upper limit of its share repurchase price to 65.04 yuan per share, with a total repurchase amount of 6.9583 million yuan for 198,000 shares [2] Group 2 - Aihui Long received a medical device registration certificate for the Hepatitis B virus core antibody detection kit, valid until May 28, 2030 [2][3] - Quanxin Co. plans to engage in commodity futures hedging to mitigate raw material price fluctuations, with a maximum guarantee amount of 8 million yuan [3] - Jiahua Intelligent plans to lease idle assets in Dongguan for a total rental amount of approximately 6.3193 million yuan over 6 years [3] Group 3 - Qianjiang Biochemical announced the resignation of its chairman and a director, with a new chairman to be elected [4][5] - Aerospace Morning Light was suspended from participating in military procurement activities due to violations, with internal investigations underway [6] - Guang'an Aizhong intends to establish a fund with a total scale of 70.7 million yuan, focusing on distributed wind and solar power generation [7] Group 4 - Zhejiang Medicine plans to use up to 1 billion yuan of idle funds for entrusted wealth management, with a maximum investment period of 12 months [10] - Hengrui Medicine's subsidiary received approval for clinical trials of HRS9531 injection, aimed at treating type 2 diabetes patients [11] - Taiji Co. announced the purchase of 10 million yuan in wealth management products, with a minimum holding period of 6 months [12] Group 5 - Hong Kong-listed company Huichuang Pharmaceutical received approval for the clinical trial of a spray for treating primary premature ejaculation [26][27] - Haichuang Pharmaceutical's new drug application for a prostate cancer treatment was approved by the National Medical Products Administration [28] - Zhuhai Guanyu was selected as a designated supplier for low-voltage lithium batteries by SAIC Volkswagen [29] Group 6 - Huayi Technology opened a tax refund service for overseas travelers, enhancing its retail offerings [32] - Baobian Electric plans to transfer 90% of its subsidiary's shares for 137 million yuan [33] - Yiwei Communication intends to invest 100 million yuan to establish a wholly-owned subsidiary to enhance its strategic layout [34]